3D Bioprinting for Personalized Medicine

Dear Colleagues,

3D bioprinting enables rapid customization of personalized devices, drugs and applications, achieving the ability to restore the tissue functionality. 

The manufacturing of these devices requires the implementation of a new type of bio-factory, industry 5.0. In the society 5.0, this type of production paradigm uses artificial intelligence for the optimal management of process data. Hence, it is mandatory to structure the human-cyber-physical space through the global standard method for society 5.0, developing digital bio-libraries linked to a specific pathology, processing data for disease regression and rehabilitation therapy. 

The pathological bio-library must take into consideration all the aspects related to the design and the development of the aforementioned biological systems, taking into account all the phases required to achieve smart bioprinting (6D).

This special issue aims to collect research articles related to the 3D printing of: biosensors capable to collect data and support the big-data chain; drug delivery devices to test pharmacological therapy; bio-composite materials to enable tissue regeneration and, scalable in-vivo validation methods on biosynthetic models supporting 3Rs by using 3D bioprinting.  

The goal is to support bioengineers, biologists and innovation managers in the development of future industry 5.0 and digital libraries related to bionic and biosynthetic design, at the basis of artificial intelligences adoption within hospitals and healthcare systems.

Prof. Dr. Ruben Foresti
Prof. Dr. Maddalena Botti
Prof. Dr. Fabio Leonardi
Dr. Pasquale D'Angelo
Prof. Dr. Roberto Sala
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.